Role of vitamin D in the hygiene hypothesis: The interplay between vitamin D, vitamin D receptors, gut microbiota, and immune response

Frontiers in Immunology

Volumn 7, Issue DEC, 2016, Pages

  Clark, Allison ^a   Mach, Núria ^a,b  

^a UNIVERSITAT OBERTA DE CATALUNYA   (Spain)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Autoimmune diseases; Gut microbiota; Hygiene hypothesis; Vitamin D; Vitamin D deficiency; Vitamin D receptor; Western lifestyle

Indexed keywords

BETA DEFENSIN; CATHELICIDIN; POLYPEPTIDE ANTIBIOTIC AGENT; VITAMIN D; VITAMIN D RECEPTOR;

AUTOIMMUNE DISEASE; AUTOPHAGY; CHEMICAL INTERACTION; FOLLOW UP; HUMAN; HYGIENE HYPOTHESIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INTESTINE FLORA; MOUSE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; REVIEW; SYSTEMATIC REVIEW;

EID: 85009399307     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00627     Document Type: Review

References (113)

1. Strachan DP. Hay fever, hygiene, and household size. BMJ (1989) 299:1259-60. doi: 10.1136/bmj.299.6710.1259
2. Cho I, Blaser MJ. The Human Microbiome: at the interface of health and disease. Nat Rev Genet (2012) 13:260-70. doi:10.1038/nrg3182
3. Proal AD, Albert PJ, Marshall TG. The human microbiome and autoimmunity. Curr Opin Rheumatol (2013) 25:234-40. doi:10.1097/BOR.0b013e32835cedbf
4. Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G, et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun (2014) 5:3654. doi:10.1038/ncomms4654
5. Weiss ST, Litonjua AA. Vitamin D, the gut microbiome, and the hygiene hypothesis. How does asthma begin? Am J Respir Crit Care Med (2015) 191:492-3. doi:10.1164/rccm.201501-0117ED
6. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol (2007) 120:1031-5. doi:10.1016/j.jaci.2007.08.028
7. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (2015) 349:g7647. doi:10.1136/bmj.g7647
8. Logan AC, Katzman MA, Balanzá-Martínez V. Natural environments, ancestral diets, and microbial ecology: is there a modern "paleo-deficit disorder"? Part II. J Physiol Anthropol (2015) 34:9. doi:10.1186/s40101-014-0040-4
9. Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan BJ, et al. Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci U S A (2015) 112:E2930-8. doi:10.1073/pnas.1423854112
10. Lepage P, Leclerc MC, Joossens M, Mondot S, Blottière HM, Raes J, et al. A metagenomic insight into our gut's microbiome. Gut (2013) 62:146-58. doi:10.1136/gutjnl-2011-301805
11. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell (2012) 148:1258-70. doi:10.1016/j.cell.2012.01.035
12. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature (2012) 489:220-30. doi:10.1038/nature11550
13. Jašarevic E, Rodgers AB, Bale TL. A novel role for maternal stress and microbial transmission in early life programming and neurodevelopment. Neurobiol Stress (2015) 1:81-8. doi:10.1016/j.ynstr.2014.10.005
14. Owen JL, Mohamadzadeh M. Microbial activation of gut dendritic cells and the control of mucosal immunity. J Interferon Cytokine Res (2013) 33:619-31. doi:10.1089/jir.2013.0046
15. Vighi G, Marcucci F, Sensi L, Di Cara G, Frati F. Allergy and the gastrointestinal system. Clin Exp Immunol (2008) 153:3-6. doi:10.1111/j.1365-2249.2008.03713.x
16. Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G, Ianiro G, et al. The role of intestinal microbiota and the immune system. Eur Rev Med Pharmacol Sci (2013) 17:323-33.
17. Wu H-J, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes (2012) 3:4-14. doi:10.4161/gmic.19320
18. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol (2009) 7:887-94. doi:10.1038/nrmicro2245
19. Rook GA. Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol (2012) 42:5-15. doi:10.1007/s12016-011-8285-8
20. Versini M, Jeandel P-Y, Bashi T, Bizzaro G, Blank M, Shoenfeld Y. Unraveling the hygiene hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med (2015) 13:81. doi:10.1186/s12916-015-0306-7
21. Ramanan D, Bowcutt R, Lee SC, Tang MS, Kurtz ZD, Ding Y, et al. Helminth infection promotes colonization resistance via type 2 immunity. Science (2016) 352:608-12. doi:10.1126/science.aaf3229
22. Martínez I, Stegen JC, Maldonado-Gómez MX, Eren AM, Siba PM, Greenhill AR, et al. The gut microbiota of rural Papua New Guineans: composition, diversity patterns, and ecological processes. Cell Rep (2015) 11:527-38. doi:10.1016/j.celrep.2015.03.049
23. Clemente JC, Pehrsson EC, Blaser MJ, Sandhu K, Gao Z, Wang B, et al. The microbiome of uncontacted Amerindians. Sci Adv (2015) 1:e1500183. doi:10.1126/sciadv.1500183
24. Filippo CD, Cavalieri D, Paola MD, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 107:14691-6. doi:10.1073/pnas.1005963107
25. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J (2010) 4:232-41. doi:10.1038/ismej.2009.112
26. Deehan EC, Walter J. The fiber gap and the disappearing gut microbiome: implications for human nutrition. Trends Endocrinol Metab (2016) 27:239-42. doi:10.1016/j.tem.2016.03.001
27. Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature (2016) 529:212-5. doi:10.1038/nature16504
28. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol (2016) 7:185. doi:10.3389/fmicb.2016.00185
29. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev (2012) 12:127-36. doi:10.1016/j.autrev.2012.07.007
30. Ermann J, Fathman CG. Autoimmune diseases: genes, bugs and failed regulation. Nat Immunol (2001) 2:759-61. doi:10.1038/ni0901-759
31. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev (2010) 9:709-15. doi:10.1016/j.autrev.2010.06.009
32. Shin JS, Choi MY, Longtine MS, Nelson DM. Vitamin D effects on pregnancy and the placenta. Placenta (2010) 31:1027-34. doi:10.1016/j.placenta.2010.08.015
33. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 376:180-8. doi:10.1016/S0140-6736(10)60588-0
34. Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science (2016) 352:565-9. doi:10.1126/science.aad3369
35. Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 4:1095-119. doi:10.3390/nu4081095
36. Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol (2016) 14:273-87. doi:10.1038/nrmicro.2016.17
37. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, et al. Population-level analysis of gut microbiome variation. Science (2016) 352:560-4. doi:10.1126/science.aad3503
38. Wilson ID, Nicholson JK. The role of gut microbiota in drug response. Curr Pharm Des (2009) 15:1519-23. doi:10.2174/138161209788168173
39. Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 88:720-55. doi:10.1016/j.mayocp.2013.05.011
40. Aranow C. Vitamin D and the immune system. J Investig Med (2011) 59:881-6. doi:10.231/JIM.0b013e31821b8755
41. Proal AD, Albert PJ, Marshall TG. Dysregulation of the vitamin D nuclear receptor may contribute to the higher prevalence of some autoimmune diseases in women. Ann N Y Acad Sci (2009) 1173:252-9. doi:10.1111/j.1749-6632.2009.04672.x
42. Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol (2011) 42:71-8. doi:10.1007/s12016-011-8291-x
43. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) (2010) 88:441-50. doi:10.1007/s00109-010-0590-9
44. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr (2008) 87:1080S-6S. doi:10.1097/00017285-199503000-00005
45. Reichrath J, Zouboulis CC, Vogt T, Holick MF. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: an historical view and outlook. Rev Endocr Metab Disord (2016) 17:405-17. doi:10.1007/s11154-016-9353-4
46. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol (2014) 21:319-29. doi:10.1016/j.chembiol.2013.12.016
47. Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol (2009) 4:1151. doi:10.2217/fmb.09.87
48. Zhang Y, Leung DYM, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D inhibits monocyte/macrophage pro-inflammatory cytokine production by targeting mitogen-activated protein kinase phosphatase 1. J Immunol (2012) 188:2127-35. doi:10.4049/jimmunol.1102412
49. Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol (2010) 26:591-5. doi:10.1097/MOG.0b013e32833d4b9f
50. World Health Organization, Food and Agricultural Organization of the United Nations. Vitamin and Mineral Requirements in Human Nutrition. WHO (2004). Available from: http://www.who.int/nutrition/publications/micronutrients/9241546123/en/
51. Johns LE, Ferguson KK, Meeker JD. Relationships between urinary phthalate metabolite and bisphenol A concentrations and vitamin D levels in U.S. adults: National Health and Nutrition Examination Survey (NHANES), 2005-2010. J Clin Endocrinol Metab (2016) 101:4062-9. doi:10.1210/jc.2016-2134
52. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 96:1911-30. doi:10.1210/jc.2011-0385
53. Palacios C, De-Regil LM, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation during pregnancy: updated meta-analysis on maternal outcomes. J Steroid Biochem Mol Biol (2016) 164:148-55. doi:10.1016/j.jsbmb.2016.02.008
54. Spiro A, Buttriss JL. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull (2014) 39:322-50. doi:10.1111/nbu.12108
55. Nwaru BI, Ahonen S, Kaila M, Erkkola M, Haapala A-M, Kronberg-Kippilä C, et al. Maternal diet during pregnancy and allergic sensitization in the offspring by 5yrs of age: a prospective cohort study. Pediatr Allergy Immunol (2010) 21:29-37. doi:10.1111/j.1399-3038.2009.00949.x
56. Wagner CL, Hulsey TC, Fanning D, Ebeling M, Hollis BW. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med (2006) 1:59-70. doi:10.1089/bfm.2006.1.59
57. Genuis SJ. Maternal and pediatric health outcomes in relation to gestational vitamin D sufficiency. Obstet Gynecol Int (2015) 2015:501829. doi:10.1155/2015/501829
58. Disanto G, Chaplin G, Morahan JM, Giovannoni G, Hyppönen E, Ebers GC, et al. Month of birth, vitamin D and risk of immune-mediated disease: a case control study. BMC Med (2012) 10:69. doi:10.1186/1741-7015-10-69
59. Mirzaei F, Michels KB, Munger K, O'Reilly E, Chitnis T, Forman MR, et al. Gestational vitamin D and the risk of multiple sclerosis in the offspring. Ann Neurol (2011) 70:30-40. doi:10.1002/ana.22456
60. Sørensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC. Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes (2012) 61:175-8. doi:10.2337/db11-0875
61. Dawodu A, Wagner CL. Prevention of vitamin D deficiency in mothers and infants worldwide-a paradigm shift. Paediatr Int Child Health (2012) 32:3-13. doi:10.1179/1465328111Y.0000000024
62. Lucas RM, Ponsonby A-L, Pasco JA, Morley R. Future health implications of prenatal and early-life vitamin D status. Nutr Rev (2008) 66:710-20. doi:10.1111/j.1753-4887.2008.00126.x
63. Chen S-W, Wang P-Y, Zhu J, Chen G-W, Zhang J-L, Chen Z-Y, et al. Protective effect of 1, 25-dihydroxyvitamin D3 on lipopolysaccharide-induced intestinal epithelial tight junction injury in caco-2 cell monolayers. Inflammation (2015) 38:375-83. doi:10.1007/s10753-014-0041-9
64. Hollis BW, Wagner CL, Howard CR, Ebeling M, Shary JR, Smith PG, et al. Maternal versus infant vitamin D supplementation during lactation: a randomized controlled trial. Pediatrics (2015) 136:625-34. doi:10.1542/peds.2015-1669
65. Clancy N, Onwuneme C, Carroll A, McCarthy R, McKenna MJ, Murphy N, et al. Vitamin D and neonatal immune function. J Matern Fetal Neonatal Med (2013) 26:639-46. doi:10.3109/14767058.2012.746304
66. Mulligan ML, Felton SK, Riek AE, Bernal-Mizrachi C. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol (2010) 202:.e1-9. doi:10.1016/j.ajog.2009.09.002
67. Pérez-López FR, Pasupuleti V, Mezones-Holguin E, Benites-Zapata VA, Thota P, Deshpande A, et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril (2015) 103:1278-88.e4. doi:10.1016/j.fertnstert.2015.02.019
68. Ananthakrishnan AN, Cagan A, Gainer VS, Cheng S-C, Cai T, Szolovits P, et al. Higher plasma 25(OH)D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther (2014) 39:1136-42. doi:10.1111/apt.12706
69. Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, et al. Gut microbiota in MS: possible influence of immunomodulators. J Investig Med (2015) 63:729-34. doi:10.1097/JIM.0000000000000192
70. Mielcarz DW, Kasper LH. The gut microbiome in multiple sclerosis. Curr Treat Options Neurol (2015) 17:344. doi:10.1007/s11940-015-0344-7
71. Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology (2010) 151:2423-32. doi:10.1210/en.2010-0089
72. Assa A, Vong L, Pinnell LJ, Avitzur N, Johnson-Henry KC, Sherman PM. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis (2014) 210:1296-305. doi:10.1093/infdis/jiu235
73. Ooi JH, Chen J, Cantorna MT. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol Aspects Med (2012) 33:77-82. doi:10.1016/j.mam.2011.10.014
74. Yahav S, Buffenstein R. Cholecalciferol supplementation alters gut function and improves digestibility in an underground inhabitant, the naked mole rat (Heterocephalus glaber), when fed on a carrot diet. Br J Nutr (1993) 69:233-41. doi:10.1079/BJN19930025
75. Zhang Y, Wu S, Sun J. Vitamin D, vitamin D receptor and tissue barriers. Tissue Barriers (2013) 1:e23118. doi:10.4161/tisb.23118
76. Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays (2004) 26:21-8. doi:10.1002/bies.10368
77. Meyer MB, Goetsch PD, Pike JW. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha, 25-dihydroxyvitamin D3. J Biol Chem (2010) 285:15599-610. doi:10.1074/jbc.M110.119958
78. Schedel M, Jia Y, Michel S, Takeda K, Domenico J, Joetham A, et al. 1, 25D3 prevents CD8+Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoter. Nat Commun (2016) 7:10213. doi:10.1038/ncomms10213
79. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1, 25-dihydroxyvitamin D3 Is a direct inducer of antimicrobial peptide gene expression. J Immunol (2004) 173:2909-12. doi:10.4049/jimmunol.173.5.2909
80. Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol (2007) 8:5. doi:10.1186/1471-2172-8-5
81. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol (2002) 2:1017-28. doi:10.1016/S1567-5769(02)00049-8
82. Cantorna MT, McDaniel K, Bora S, Chen J, James J. Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med (Maywood) (2014) 239:1524-30. doi:10.1177/1535370214523890
83. Dilworth FJ, Chambon P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene (2001) 20:3047-54. doi:10.1038/sj.onc.1204329
84. Tapp HS, Commane DM, Bradburn DM, Arasaradnam R, Mathers JC, Johnson IT, et al. Nutritional factors and gender influence age-related DNA methylation in the human rectal mucosa. Aging Cell (2013) 12:148-55. doi:10.1111/acel.12030
85. Zhu H, Wang X, Shi H, Su S, Harshfield GA, Gutin B, et al. A genome-wide methylation study of severe vitamin D deficiency in African American adolescents. J Pediatr (2013) 162:1004-9. doi:10.1016/j.jpeds.2012.10.059
86. Pilon C, Rebellato A, Urbanet R, Guzzardo V, Cappellesso R, Sasano H, et al. Methylation status of vitamin D receptor gene promoter in benign and malignant adrenal tumors. Int J Endocrinol (2015) 2015:375349. doi:10.1155/2015/375349
87. Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh J-C, Slater S, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev (2008) 66:S98-112. doi:10.1111/j.1753-4887.2008.00093.x
88. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science (2002) 296:1313-6. doi:10.1126/science.1070477
89. Wu S, Liao AP, Xia Y, Li YC, Li J-D, Sartor RB, et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-κB activity in intestine. Am J Pathol (2010) 177:686-97. doi:10.2353/ajpath.2010.090998
90. Liu W, Chen Y, Golan MA, Annunziata ML, Du J, Dougherty U, et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest (2013) 123:3983-96. doi:10.1172/JCI65842
91. Veldhoen M, Brucklacher-Waldert V. Dietary influences on intestinal immunity. Nat Rev Immunol (2012) 12:696-708. doi:10.1038/nri3299
92. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Rev Rheumatol (2008) 4:404-12. doi:10.1038/ncprheum0855
93. Yuk J-M, Shin D-M, Lee H-M, Yang C-S, Jin HS, Kim K-K, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe (2009) 6:231-43. doi:10.1016/j.chom.2009.08.004
94. Albert PJ, Proal AD, Marshall TG. Vitamin D: the alternative hypothesis. Autoimmun Rev (2009) 8:639-44. doi:10.1016/j.autrev.2009.02.011
95. Rajapakse R, Uring-Lambert B, Andarawewa KL, Rajapakse RP, Abou-Bacar A, Marcellin L, et al. 1, 25(OH)2D3 inhibits in vitro and in vivo intracellular growth of apicomplexan parasite Toxoplasma gondii. J Steroid Biochem Mol Biol (2007) 103:811-4. doi:10.1016/j.jsbmb.2006.12.058
96. Zhao H, Zhang H, Wu H, Li H, Liu L, Guo J, et al. Protective role of 1, 25(OH)2vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol (2012) 12:57. doi:10.1186/1471-230X-12-57
97. Wu S, Zhang Y, Lu R, Xia Y, Zhou D, Petrof EO, et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut (2015) 64:1082-94. doi:10.1136/gutjnl-2014-307436
98. Chen J, Waddell A, Lin Y-D, Cantorna MT. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells. Mucosal Immunol (2015) 8:618-26. doi:10.1038/mi.2014.94
99. Wang J, Thingholm LB, Skieceviciene J, Rausch P, Kummen M, Hov JR, et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat Genet (2016) 48:1396-406. doi:10.1038/ng.3695
100. Chen Y-H, Yu Z, Fu L, Wang H, Chen X, Zhang C, et al. Vitamin D3 inhibits lipopolysaccharide-induced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit. Sci Rep (2015) 5:10871. doi:10.1038/srep10871
101. Jin D, Wu S, Zhang Y, Lu R, Xia Y, Dong H, et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther (2015) 37:996-1009. doi:10.1016/j.clinthera.2015.04.004
102. Waterhouse JC, Perez TH, Albert PJ. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann N Y Acad Sci (2009) 1173:757-65. doi:10.1111/j.1749-6632.2009.04637.x
103. Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the infection connection. Inflamm Res (2014) 63:803-19. doi:10.1007/s00011-014-0755-z
104. Ridlon JM, Bajaj JS. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharm Sin B (2015) 5:99-105. doi:10.1016/j.apsb.2015.01.006
105. Labuda M, Fujiwara TM, Ross MV, Morgan K, Garcia-Heras J, Ledbetter DH, et al. Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13-14. J Bone Miner Res (1992) 7:1447-53. doi:10.1002/jbmr.5650071212
106. Kamel MM, Fouad SA, Salah El Din O, El-Razek Ael-R, El-Fatah Al. Impact of vitamin D receptor gene polymorphisms in pathogenesis of type-1 diabetes mellitus. Int J Clin Exp Med (2014) 7:5505-10.
107. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A (1992) 89:6665-9. doi:10.1073/pnas.89.15.6665
108. Lee YH, Bae S-C, Choi SJ, Ji JD, Song GG. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep (2011) 38:3643-51. doi:10.1007/s11033-010-0477-4
109. Abdollahzadeh R, Fard MS, Rahmani F, Moloudi K, Kalani BS, Azarnezhad A. Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: a case-control study. J Neurol Sci (2016) 367:148-51. doi:10.1016/j.jns.2016.05.053
110. Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut (2000) 47:211-4. doi:10.1136/gut.47.2.211
111. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature (2012) 486:222-7. doi:10.1038/nature11053
112. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med (2011) 17:330-9. doi:10.1038/nm.2305
113. Fetahu IS, Höbaus J, Kállay E. Vitamin D and the epigenome. Front Physiol (2014) 5:164. doi:10.3389/fphys.2014.00164